Metachromatic leukodystrophy: an overview of current and prospective treatments

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Bone Marrow Transplantation

• Publication date

  2008-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/bmt.2008.275PMID 18978739
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• THE METABOLIC AND MOLECULAR BASES OF INHERITED DISEASE

  2010cited by this paper
• Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report

  2008cited by this paper
• Emerging trends in transplantation of inherited metabolic diseases

  2008cited by this paper
• The controversial and changing role of haematopoietic cell transplantation for lysosomal storage disorders: an update

  2008cited by this paper
• 169: Neurodevelopmental outcomes of children with MPS II after unrelated umbilical cord blood transplantation

  2007cited by this paper
• Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure

  2007cited by this paper
• Early marrow transplantation in a pre-symptomatic neonate with late infantile metachromatic leukodystrophy does not halt disease progression

  2007cited by this paper
• New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy

  2007cited by this paper
• 168: Neurodevelopmental outcomes of unrelated umbilical cord blood tansplantation for metachromatic leukodystrophy

  2007cited by this paper
• Novel candidate disease for gene therapy: metachromatic leukodystrophy

  2007cited by this paper
• Stabilization of Juvenile Metachromatic Leukodystrophy After Bone Marrow Transplantation: A 13-Year Follow-up

  2007cited by this paper
• Safety of Arylsulfatase A Overexpression for Gene Therapy of Metachromatic Leukodystrophy

  2007cited by this paper
• Enzyme, cell and gene-based therapies for metachromatic leukodystrophy

  2007cited by this paper
• Hematopoietic cell therapy for metabolic disease.

  2007cited by this paper
• Transplantation of Umbilical-Cord Blood in Babies With Infantile Krabbe's Disease

  2007cited by this paper
• Trends in haematopoietic cell transplantation for inborn errors of metabolism

  2006cited by this paper
• Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

  2006cited by this paper
• Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice.

  2006cited by this paper
• Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease.

  2005cited by this paper
• Lysosomal storage disorders

  2005cited by this paper
• Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy.

  2005cited by this paper
• Cord-blood transplants from unrelated donors in patients with Hurler's syndrome.

  2004cited by this paper
• Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells.

  2004cited by this paper
• Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases

  2004cited by this paper
• Prevalence of lysosomal storage diseases in Portugal

  2004cited by this paper
• Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines

  2003cited by this paper
• Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources

  2003cited by this paper
• Identification of nine novel arylsulfatase a (ARSA) gene mutations in patients with metachromatic leukodystrophy (MLD)

  2003cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors.

  2000cited by this paper
• Slow Progression of Juvenile Metachromatic Leukodystrophy 6 Years After Bone Marrow Transplantation

  1999cited by this paper
• The frequency of lysosomal storage diseases in The Netherlands

  1999cited by this paper
• Long-term stabilization after bone marrow transplantation in juvenile metachromatic leukodystrophy.

  1998cited by this paper
• Practical Suggestions in Diagnosing Metachromatic Leukodystrophy in Probands andin Testing Family Members

  1998cited by this paper
• Improved peripheral nerve conduction, EEG and verbal IQ after bone marrow transplantation for adult metachromatic leukodystrophy

  1998cited by this paper
• Two new polymorphisms in the arylsulfatase A gene and their haplotype associations with normal, metachromatic leukodystrophy and pseudodeficiency alleles.

  1997cited by this paper
• Occurrence, distribution, and phenotype of arylsulfatase A mutations in patients with metachromatic leukodystrophy.

  1997cited by this paper
• Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation.

  1996cited by this paper
• Late juvenile metachromatic leukodystrophy treated with bone marrow transplantation

  1996cited by this paper
• Molecular analysis of the arylsulphatase A gene in late infantile metachromatic leucodystrophy patients and healthy subjects from Italy.

  1996cited by this paper
• Allogeneic bone marrow transplantation for lysosomal storage diseases

  1995cited by this paper
• Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation

  1995cited by this paper
• Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation.

  1995cited by this paper
• Molecular genetics of metachromatic leukodystrophy

  1994cited by this paper
• Molecular genetics of metachromatic leukodystrophy

  1994cited by this paper
• Diseases of the Nervous System in Childhood

  1993cited by this paper
• Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis.

  1992cited by this paper
• Molecular basis of different forms of metachromatic leukodystrophy.

  1991cited by this paper
• Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease.

  1991cited by this paper
• The assay of arylsulphatases A and B in human urine.

  1959cited by this paper

• A Rare Case of Metachromatic Leukodystrophy (MLD)

  2025cites this paper
• Protein misfolding and neurodegeneration: Mechanisms, implications, and therapeutic strategies.

  2025cites this paper
• Current Advances and Challenges in Gene Therapies for Neurologic Disorders

  2025cites this paper
• Stem cell and gene therapies for leukodystrophies

  2025influential citation
• Metachromatic Leukodystrophy Presenting with Multiple Cranial Nerve and Lumbosacral Nerve Root Enhancement Without White Matter Changes

  2025cites this paper
• Juvenile metachromatic leukodystrophy caused by a rare genetic mutation

  2025cites this paper
• Ichthyosis and ARSA deficiency: An unusual clinical presentation

  2025cites this paper
• Clinical and Radiological Profile of Nine Patients with Metachromatic Leukodystrophy

  2024cites this paper
• Exploring the effect of disease causing mutations in metal binding sites of human ARSA in metachromatic leukodystrophy.

  2024cites this paper
• Lentivirus-modified hematopoietic stem cell gene therapy for advanced symptomatic juvenile metachromatic leukodystrophy: a long-term follow-up pilot study

  2024cites this paper
• ARSA Variant Associated With Late Infantile Metachromatic Leukodystrophy and Carrier Rate in Individuals of Ashkenazi Jewish Ancestry

  2024cites this paper
• Novel in-frame duplication variant characterization in late infantile metachromatic leukodystrophy using whole-exome sequencing and molecular dynamics simulation

  2023cites this paper
• Zebra-Sphinx: Modeling Sphingolipidoses in Zebrafish

  2023cites this paper
• Predicting clinical phenotypes of metachromatic leukodystrophy based on the arylsulfatase A activity and the ARSA genotype? - Chances and challenges.

  2022cites this paper
• Delineating the Neuropathology of Lysosomal Storage Diseases Using Patient-Derived Induced Pluripotent Stem Cells

  2022cites this paper
• The Role of Sphingomyelin and Ceramide in Motor Neuron Diseases

  2022cites this paper
• Rare Diseases in Glycosphingolipid Metabolism.

  2022cites this paper
• Identification of neurodegeneration indicators and disease progression in metachromatic leukodystrophy using quantitative NMR‐based urinary metabolomics

  2022cites this paper
• Lipidoses: The Sphingolipidoses, Lysosomal Acid Lipase Deficiency, and Niemann-Pick Type C

  2022cites this paper
• Mesenchymal Stem Cell-Based Therapy for Lysosomal Storage Diseases and Other Neurodegenerative Disorders

  2022cites this paper
• Case report: A compound heterozygous mutations in ARSA associated with adult-onset metachromatic leukodystrophy

  2022cites this paper
• Formation of multinucleated globoid cells in Krabbe iPSC-derived microglia cultures: a preliminary investigation

  2021cites this paper
• Metachromatic Leukodystrophy: Diagnosis and Treatment Challenges

  2021cites this paper
• Lysosomal Storage Disorders

  2021cites this paper
• Genetic analysis of a family with metachromatic leukodystrophy

  2021cites this paper
• Novel disease-causing variants in a cohort of Iranian patients with metachromatic leukodystrophy and in silico analysis of their pathogenicity.

  2020cites this paper
• Lysosomal sulfatases: a growing family.

  2020cites this paper
• Viral-Mediated Gene Replacement Therapy in the Developing Central Nervous System: Current Status and Future Directions.

  2020cites this paper
• Chinese Cases of Metachromatic Leukodystrophy with the Novel Missense Mutations in ARSA Gene

  2020cites this paper
• Early clinical course after hematopoietic stem cell transplantation in children with juvenile metachromatic leukodystrophy

  2020cites this paper
• Clinical, Biochemical, and Molecular Characterization of Metachromatic Leukodystrophy Among Egyptian Pediatric Patients: Expansion of the ARSA Mutational Spectrum

  2020cites this paper
• Brain Penetrable Inhibitors of Ceramide Galactosyltransferase for the Treatment of Lysosomal Storage Disorders.

  2020cites this paper
• Toddler With Frequent Falls and Neuroregression: Imaging Clues!

  2020cites this paper
• T2-Pseudonormalization and Microstructural Characterization in Advanced Stages of Late-infantile Metachromatic Leukodystrophy

  2020cites this paper
• Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers

  2019cites this paper
• Survey of quality of life, phenotypic expression, and response to treatment in Krabbe leukodystrophy

  2019cites this paper
• Pharmacokinetic Modeling of Intrathecally Administered Recombinant Human Arylsulfatase A (TAK‐611) in Children With Metachromatic Leukodystrophy

  2019influential citation
• Electroneurography and Advanced Neuroimaging Profile in Pediatric-onset Metachromatic Leukodystrophy

  2019cites this paper
• Identification of a missense ARSA mutation in metachromatic leukodystrophy and its potential pathogenic mechanism

  2019cites this paper
• Two siblings with metachromatic leukodystrophy caused by a novel identified homozygous mutation in the ARSA gene

  2018cites this paper
• Central Precocious Puberty in a Child With Metachromatic Leukodystrophy

  2018cites this paper
• Cellular Therapy in Rare Childhood Neurologic Disease: Lessons, Outcomes, and Access

  2018cites this paper
• Clinical implications of myelin regeneration in the central nervous system

  2018cites this paper
• Metachromatic leukodystrophy: Natural evolution and treatment effects

  2018influential citation
• Gene Therapy for Nonmalignant Hematology

  2018cites this paper
• Identification of Novel ARSA Mutations in Chinese Patients with Metachromatic Leukodystrophy

  2018cites this paper
• Intrathecal baclofen in metachromatic leukodystrophy

  2018cites this paper
• Intrathecal Baclofen Pump Implantation for Type 2 Gaucher Disease

  2017cites this paper
• Metachromatic Leukodystrophy (MLD): a Pakistani Family with Novel ARSA Gene Mutation

  2017cites this paper
• Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms

  2017cites this paper
• Identification of a novel mutation in ARSA gene in three patients of an Iranian family with metachromatic leukodystrophy disorder

  2017cites this paper
• Current Perspective of Stem Cell Therapy in Neurodegenerative and Metabolic Diseases

  2017cites this paper
• Quantitative MR spectroscopic imaging in metachromatic leukodystrophy: value for prognosis and treatment

  2017cites this paper
• Metachromasia and Metachromatic Dyes : A review A

  2016cites this paper
• Outcome of Early Juvenile Onset Metachromatic Leukodystrophy After Unrelated Cord Blood Transplantation: A Case Series and Review of the Literature

  2016cites this paper
• Glyphosate pathways to modern diseases V : Amino acid analogue of glycine in diverse proteins

  2016cites this paper
• Disorders of Sphingolipid Synthesis, Sphingolipidoses, Niemann-Pick Disease Type C and Neuronal Ceroid Lipofuscinoses

  2016cites this paper
• Infantile metachromatic leukodystrophy in an 18 month old girl.

  2016cites this paper
• Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients.

  2016cites this paper
• Acetobacter indonesiensis Bacteremia in Child with Metachromatic Leukodystrophy

  2016cites this paper
• Engineering Stem Cells for Biomedical Applications

  2016cites this paper
• Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy

  2016cites this paper
• Efficacy of hematopoietic cell transplantation in metachromatic leukodystrophy: the Dutch experience.

  2016cites this paper
• Cord blood is the optimal graft source for the treatment of pediatric patients with lysosomal storage diseases: clinical outcomes and future directions.

  2015cites this paper
• Metachromatic leukodystrophy: Disease spectrum and approaches for treatment.

  2015cites this paper
• Genotypic characterization of Brazilian patients with infantile and juvenile forms of metachromatic leukodystrophy.

  2015influential citation
• Pathology of the Gallbladder in a Child with Metachromatic Leukodystrophy

  2015cites this paper
• Abnormalities of acid-base balance and predisposition to metabolic acidosis in Metachromatic Leukodystrophy patients.

  2015cites this paper
• Immunodeficiencies and Metabolic Diseases

  2015cites this paper
• Developing Mesenchymal Stromal Cell Therapy for Neurodegenerative Diseases using the Murine Models of Globoid Cell Leukodystrophy and Multiple Sclerosis

  2015cites this paper
• Prenatal Diagnosis of Disorders of Lipid Metabolism

  2015cites this paper
• Hematopoietic stem cell transplantation for metachromatic leukodystrophy

  2015cites this paper
• Production of self-inactivating lentiviral vectors by constitutive packaging cell lines for gene therapy clinical applications

  2015cites this paper
• Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy

  2014cites this paper
• Mesenchymal stem cells as cellular vectors for pediatric neurological disorders.

  2014cites this paper
• Lentiviral vectors containing mouse Csf1r control elements direct macrophage-restricted expression in multiple species of birds and mammals

  2014cites this paper
• Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses

  2014cites this paper
• The Complementary Role of the Kinect Virtual Reality Game Training in a Patient With Metachromatic Leukodystrophy

  2014cites this paper
• Stem Cells in Neurological Disorders: Emerging Therapy with Stunning Hopes

  2014cites this paper
• Leukodystrophies and Lysosomal Storage Disorders

  2013cites this paper
• Biffi Metachromatic Leukodystrophy Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits

  2013cites this paper
• Developing therapeutic approaches for metachromatic leukodystrophy

  2013cites this paper
• Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy.

  2013cites this paper
• Juvenile metachromatic leukodystrophy 10 years post transplant compared with a non-transplanted cohort

  2013cites this paper
• Stem Cell Therapy in Lysosomal Storage Diseases

  2013cites this paper
• Hematopoietic Stem Cell Gene Therapy for Lysosomal Storage Disorders: Expected Benefits and Limitations

  2013cites this paper
• Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy

  2013cites this paper
• Sphingolipid Disorders and the Neuronal Ceroid Lipofuscinoses or Batten Disease (Wolman Disease, Cholesteryl Ester Storage Disease, and Cerebrotendinous Xanthomatosis)

  2013cites this paper
• A patient presenting a 22q13 deletion associated with an apparently balanced translocation t(16;22): An illustrative case in the investigation of patients with low ARSA activity

  2012cites this paper
• A semi-automatic algorithm for determining the demyelination load in metachromatic leukodystrophy.

  2012cites this paper
• Metachromatic leukodystrophy – what is new?

  2012cites this paper
• Stem Cell-Based Therapy for Lysosomal Storage Diseases

  2012cites this paper
• Disorders of Sphingolipid Metabolism and Neuronal Ceroid-Lipofuscinoses

  2012cites this paper
• Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population

  2012cites this paper
• Stem Cells and Human Diseases

  2012cites this paper
• Long‐term neuroimaging follow‐up on an asymptomatic juvenile metachromatic leukodystrophy patient after hematopoietic stem cell transplantation: Evidence of myelin recovery and ongoing brain maturation

  2012cites this paper
• Developing treatment options for metachromatic leukodystrophy.

  2012cites this paper
• White matter dementia

  2012cites this paper
• Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature

  2011cites this paper
• Neural stem cell transplantation : neuroprotection and LTP-induced facilitation of neurogenesis

  2011cites this paper